Clinical presentations of adult patients with ADHDADLER, Lenard A.The Journal of clinical psychiatry. Supplement. 2004, Vol 65, Num 3, pp 8-11, 4 p.Conference Paper

Management of ADHD in adultsADLER, Lenard A; CHUA, Hong C.The Journal of clinical psychiatry. Supplement. 2002, Vol 63, Num 12, pp 29-35, 7 p.Conference Paper

Assessing attention-deficit/hyperactivity disorder in adults: Focus on rating scalesMURPHY, Kevin R; ADLER, Lenard A.The Journal of clinical psychiatry. Supplement. 2004, Vol 65, Num 3, pp 12-17, 6 p.Conference Paper

An 8-Week, Randomized Controlled Trial of Atomoxetine, Atomoxetine Plus Buspirone, or Placebo in Adults With ADHDSUTHERLAND, Suzanne M; ADLER, Lenard A; CHEN, Crystal et al.The Journal of clinical psychiatry. 2012, Vol 73, Num 4, pp 445-450, issn 0160-6689, 6 p.Article

Short-Term Effects of Lisdexamfetamine Dimesylate on Cardiovascular Parameters in a 4-Week Clinical Trial in Adults With Attention-Deficit/Hyperactivity DisorderADLER, Lenard A; WEISLER, Richard H; GOODMAN, David W et al.The Journal of clinical psychiatry. 2009, Vol 70, Num 12, pp 1662-1671, issn 0160-6689, 10 p.Article

Triple-Bead Mixed Amphetamine Salts (SPD465), a Novel, Enhanced Extended-Release Amphetamine Formulation for the Treatment of Adults With ADHD : A Randomized, Double-Blind, Multicenter, Placebo-Controlled StudySPENCER, Thomas J; ADLER, Lenard A; WEISLER, Richard H et al.The Journal of clinical psychiatry. 2008, Vol 69, Num 9, pp 1437-1448, issn 0160-6689, 12 p.Article

Functional and psychosocial impairment in adults with undiagnosed ADHDABLE, Stephen L; JOHNSTON, Joseph A; ADLER, Lenard A et al.Psychological medicine (Print). 2007, Vol 37, Num 1, pp 97-107, issn 0033-2917, 11 p.Article

Long-term, open-label study of the safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder : An interim analysisADLER, Lenard A; SPENCER, Thomas J; MILTON, Denai R et al.The Journal of clinical psychiatry. 2005, Vol 66, Num 3, pp 294-299, issn 0160-6689, 6 p.Article

Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment on Smoking Cessation Intervention in ADHD Smokers: A Randomized, Double-Blind, Placebo-Controlled TrialWINHUSEN, Theresa M; SOMOZA, Eugene C; LEWIS, Daniel F et al.The Journal of clinical psychiatry. 2010, Vol 71, Num 12, pp 1680-1688, issn 0160-6689, 9 p.Article

Atomoxetine treatment of adults with ADHD and comorbid alcohol use disordersWILENS, Timothy E; ADLER, Lenard A; AHRBECKER, Lisa M et al.Drug and alcohol dependence. 2008, Vol 96, Num 1-2, pp 145-154, issn 0376-8716, 10 p.Article

Atomoxetine Treatment of Attention-Deficit/Hyperactivity Disorder in Young Adults With Assessment of Functional Outcomes: A Randomized, Double-Blind, Placebo-Controlled Clinical TrialDURELL, Todd M; ADLER, Lenard A; WILLIAMS, Dave W et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 1, pp 45-54, issn 0271-0749, 10 p.Article

Long-Term Safety of OROS Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder: An Open-Label, Dose-Titration, 1-Year StudyADLER, Lenard A; ORMAN, Camille; STARR, H. Lynn et al.Journal of clinical psychopharmacology. 2011, Vol 31, Num 1, pp 108-114, issn 0271-0749, 7 p.Article

Reliability and validity of the Time-Sensitive ADHD Symptom Scale in adultsADLER, Lenard A; SHAW, David M; SPENCER, Thomas J et al.Comprehensive psychiatry (Print). 2011, Vol 52, Num 6, pp 769-773, issn 0010-440X, 5 p.Article

Structure and Diagnosis of Adult Attention-Deficit/Hyperactivity Disorder: Analysis of Expanded Symptom Criteria From the Adult ADHD Clinical Diagnostic ScaleKESSLER, Ronald C; GREIF GREEN, Jennifer; RUSSO, Leo J et al.Archives of general psychiatry. 2010, Vol 67, Num 11, pp 1168-1178, issn 0003-990X, 11 p.Article

A Provisional Screening Instrument for Four Common Mental Disorders in Adult Primary Care PatientsHOUSTON, John P; KROENKE, Kurt; FARIES, Douglas E et al.Psychosomatics (Washington, DC). 2011, Vol 52, Num 1, pp 48-55, issn 0033-3182, 8 p.Article

Efficacy and Safety of OROS Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Dose-Escalation StudyADLER, Lenard A; ZIMMERMAN, Brenda; STARR, H. Lynn et al.Journal of clinical psychopharmacology. 2009, Vol 29, Num 3, pp 239-247, issn 0271-0749, 9 p.Article

Addition of atomoxetine for depression incompletely responsive to sertraline : A randomized, double-blind, placebo-controlled studyMICHELSON, David; ADLER, Lenard A; AMSTERDAM, Jay D et al.The Journal of clinical psychiatry. 2007, Vol 68, Num 4, pp 582-587, issn 0160-6689, 6 p.Article

Atomoxetine and adult attention-deficit/hyperactivity disorder : The effects of comorbiditySPENCER, Thomas J; FARAONE, Stephen V; MICHELSON, David et al.The Journal of clinical psychiatry. 2006, Vol 67, Num 3, pp 415-420, issn 0160-6689, 6 p.Article

Patterns and predictors of attention-deficit/ hyperactivity disorder persistence into adulthood : Results from the national comorbidity survey replicationKESSLER, Ronald C; ADLER, Lenard A; ÜSTÜN, T. Bedirhan et al.Biological psychiatry (1969). 2005, Vol 57, Num 11, pp 1442-1451, issn 0006-3223, 10 p.Article

Atomoxetine Treatment Outcomes in Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder: Results From a Post Hoc, Pooled AnalysisADLER, Lenard A; WILENS, Timothy; SHUYU ZHANG et al.Clinical therapeutics. 2012, Vol 34, Num 2, pp 363-373, issn 0149-2918, 11 p.Article

A Translational Approach to Evaluate the Efficacy and Safety of the Novel AMPA Receptor Positive Allosteric Modulator Org 26576 in Adult Attention-Deficit/ Hyperactivity DisorderADLER, Lenard A; KROON, René A; STEIN, Mark et al.Biological psychiatry (1969). 2012, Vol 72, Num 11, pp 971-977, issn 0006-3223, 7 p.Article

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy, Safety, and Tolerability of Extended-Release Metadoxine in Adults With Attention-Deficit/Hyperactivity DisorderMANOR, Iris; BEN-HAYUN, Rachel; AHARON-PERETZ, Judith et al.The Journal of clinical psychiatry. 2012, Vol 73, Num 12, pp 1517-1523, issn 0160-6689, 7 p.Article

Attention-Deficit/Hyperactivity Disorder-Specific Quality of Life With Triple-Bead Mixed Amphetamine Salts (SPD465) in Adults : Results of a Randomized, Double-Blind, Placebo-Controlled StudySPENCER, Thomas J; LANDGRAF, Jeanne M; ADLER, Lenard A et al.The Journal of clinical psychiatry. 2008, Vol 69, Num 11, pp 1766-1775, issn 0160-6689, 10 p.Article

Treatment predictors of extrapyramidal side effects in patients with tardive dyskinesia: Results from Veterans Affairs Cooperative Study 394LOHR, James B; CALIGIURI, Michael P; EDSON, Robert et al.Journal of clinical psychopharmacology. 2002, Vol 22, Num 2, pp 196-200, issn 0271-0749Article

Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/ Hyperactivity Disorder Who Report Clinically Significant Impairment in Executive Function: Results From a Randomized, Double-Blind, Placebo-Controlled StudyADLER, Lenard A; DIRKS, Bryan; DEAS, Patrick F et al.The Journal of clinical psychiatry. 2013, Vol 74, Num 7, pp 694-702, issn 0160-6689, 9 p.Article